Th17 cells in rheumatoid arthritis;A Th17 sejtek szerepe rheumatoid arthritisben

Orvosi Hetilap

Volumn 151, Issue 25, 2010, Pages 1003-1010

  Himer, Leonóra ^a   Balog, Attila ^b   Szebeni, Beáta ^a   Nagy Szakál, Dorottya ^a   Sziksz, Erna ^a   Reusz, György ^a   Tulassay, Tivadar ^a   Vannay, Ádám ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Inflammation; Rheumatoid arthritis; Th17

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOSPORIN; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; INTERLEUKIN 17; LEFLUNOMIDE; METHOTREXATE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; SALAZOSULFAPYRIDINE; TOCILIZUMAB;

AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CELL SURFACE; CYTOKINE PRODUCTION; DRUG TARGETING; ENDOTHELIUM CELL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; LEUKOCYTE; MEDICAL RESEARCH; NEUTROPHIL; REVIEW; RHEUMATOID ARTHRITIS; TH17 CELL;

ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; HUMANS; INTERLEUKIN-17; RECEPTORS, INTERLEUKIN; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH2 CELLS;

EID: 77953177481     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2010.28880     Document Type: Review

References (48)

1. Mosmann, T. R., Cherwinski, H., Bond, M. W. és mtsai: Two types of murine helper T cell clone. I. Definition according to pro-files of lymphokine activities and secreted proteins. J. Immunol., 1986, 136, 2348-2357.
2. + regulatory T cells and for expansion of these cells. J. Immunol., 2007, 178, 2018-2027.
3. Annunziato, F., Cosmi, L., Santarlasci és mtsai: Phenotypic and functional features of human Th17 cells. J. Exp. Med., 2007, 204, 1849-1861.
4. Acosta-Rodriguez, E. V., Rivino, L., Geginat, J. és mtsai: Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol., 2007, 8, 639-646.
5. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol., 2005, 6, 1123-1132.
6. Manel, N., Unutmaz, D., Littman, D. R.: The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol., 2008, 9, 641-649.
7. Volpe, E., Servant, N., Zollinger, R. és mtsai: A critical function for transforming growth factor-beta, interleukin-23 and proin-flammatory cytokines in driving and modulating human T(H)-17 responses. Nat. Immunol., 2008, 9, 650-657.
8. Bettelli, E., Carrier, Y., Gao, W. és mtsai: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature, 2006, 441, 235-238.
9. Nistala, K., Wedderburn, L. R.: Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis. Rheumatology (Oxford), 2009, 48, 602-606.
10. Eisenstein, E. M., Williams, C. B.: The Treg/Th17 cell balance: A new paradigm for autoimmunity. Pediatr. Res., 2009, 65, 26R-31R.
11. Yang, X. O., Panopoulos, A. D., Nurieva, R. és mtsai: STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem., 2007, 282, 9358-9363.
12. + T helper cells. Cell, 2006, 126, 1121-1133.
13. Korn, T., Bettelli, E., Gao, W. és mtsai: IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature, 2007, 448, 484-487.
14. Nurieva, R., Yang, X. O., Martinez, G. és mtsai: Essential auto-crine regulation by IL-21 in the generation of inflammatory T cells. Nature, 2007, 448, 480-483.
15. Langrish, C. L., Chen, Y., Blumenschein, W. M. és mtsai: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med., 2005, 201, 233-240.
16. + T cells. J. Biol. Chem., 2007, 282, 13447-13455.
17. Chang, S. H., Dong, C.: A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses. Cell Res., 2007, 17, 435-440.
18. McAllister, F., Henry, A., Kreindler, J. L. és mtsai: Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth related oncogene-α and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J. Immunol., 2005, 175, 404-412.
19. + gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol., 2007, 178, 4466-4472.
20. Ferretti, S., Bonneau, O., Dubois, G. R. és mtsai: IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccha-ride-induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol., 2003, 170, 2106-2112.
21. Gaffen, S. L.: An overview of IL-17 function and signaling. Cytokine, 2008, 43, 402-407.
22. Shen, F., Gaffen, S. L.: Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine, 2008, 41, 92-104.
23. Li, H., Chen, J., Huang, A. és mtsai: Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 family. Proc. Natl. Acad. Sci. USA, 2000, 97, 773-778.
24. Dong, C.: Regulation and pro-inflammatory function of inter-leukin-17 family cytokines. Immunol. Rev., 2008, 226, 80-86.
25. Ishigame, H., Kakuta, S., Nagai, T. és mtsai: Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity, 2009, 30, 108-119.
26. Wright, J. F., Bennett, F., Li, B. és mtsai: The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J. Immunol., 2008, 181, 2799-2805.
27. Kuestner, R., Taft, D. W., Haran, A. és mtsai: Identification of the IL-17 receptor related molecule, IL-17RC, as the receptor for IL-17F. J. Immunol., 2007, 179, 5462-5473.
28. Yao, Z., Fanslow, W. C., Seldin, M. F. és mtsai: Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity, 1995, 3, 811-821.
29. Shen, F., Ruddy, M. J., Plamondon, P. és mtsa: Cytokines link osteoblasts and inflammation: microarray analysis of inter-leukin-17 and TNFα-induced genes in bone cells. J. Leukoc. Biol., 2005, 77, 388-399.
30. Huang, F., Kao, C. Y., Wachi, S. és mtsai: Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-κB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells. J. Immunol., 2007, 179, 6504-6513.
31. Kim, K. W., Cho, M. L., Park, M. K. és mtsai: Increased inter-leukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor κB-dependent pathway in patients with rheumatoid arthritis. Arthritis Res. Ther., 2005, 7, R139-R148.
32. Firestein, G. S.: Evolving concepts of rheumatoid arthritis. Nature, 2003, 423, 356-361.
33. Firestein, G. S.: Immunologic mechanisms in the pathogenesis of rheumatoid arthritis. J. Clin. Rheumatol., 2005, 11, S39-44.
34. Abdollahi-Roodsaz, S., Joosten, L. A., Helsen, M. M. és mtsai: Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production. Arthritis Rheum., 2008, 58, 3753-3764.
35. Nakae, S., Nambu, A., Sudo, K. és mtsa: Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol., 2003, 171, 6173-6177.
36. Kim, H. R., Kim, H. S., Park, M. K. és mtsai: The clinical role of IL-23p19 in patients with rheumatoid arthritis. Scand. J. Rheu-matol., 2007, 36, 259-264.
37. Ikeuchi, H., Kuroiwa, T., Hiramatsu, N. és mtsai: Expression of interleukin-22 in rheumatoid arthritis: potential role as a proin-flammatory cytokine. Arthritis Rheum., 2005, 52, 1037-1046.
38. Lubberts, E., Joosten, L. A., van de Loo, F. A. és mtsai: Overexpres-sion of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction. Inflamm. Res., 2002, 51, 102-104.
39. Chabaud, M., Page, G., Miossec, P.: Enhancing effect of IL-1, IL-17, and TNF-{alpha} on macrophage inflammatory protein-3{alpha} production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J. Immunol., 2001, 167, 6015-6020.
40. Pers, J. O., Daridon, C., Devauchelle, V. és mtsai: BAFF overex-pression is associated with autoantibody production in autoimmune diseases. Ann. N. Y. Acad. Sci., 2005, 1050, 34-39.
41. Shalom-Barak, T., Quach, J., Lotz, M.: Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NFkB. J. Biol. Chem., 1998, 273, 27467-27473. (Pubitemid 28500465)
42. Page, G., Miossec, P.: RANK and RANKL expression as markers of dendritic cell-T cell interactions in paired samples of rheumatoid synovium and lymph nodes. Arthritis Rheum., 2005, 52, 2307-2312.
43. Nakashima, T., Kobayashi, Y., Yamasaki, S. és mtsai: Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-κB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem. Bio-phys. Res. Commun., 2000, 275, 768-775.
44. Kikly, K., Liu, L., Na, S. és mtsai: The IL-23/Th17 axis: therapeutic targets for autoimmune inflammation. Curr. Opin. Immunol., 2006, 18, 670-675.
45. Lubberts, E., Joosten, L. A., Chabaud, M. és mtsai: IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteopro-tegerin ligand and prevents bone erosion. J. Clin. Invest., 2000, 105, 1697-1710.
46. Nadkarni, S., Mauri, C., Ehrenstein, M. R.: Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J. Exp. Med., 2007, 204, 33-39.
47. Lubberts, E.: IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis? Cytokine, 2008, 41, 84-91.
48. Deng, G. M., Zheng, L., Chan, F. K. és mtsa: Amelioration of in-flammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors. Nature Med., 2005, 11, 1066-1072.